Novel 4-substituted 2-piperazinylquinazolines as potent anticonvulsive and antihypoxic agents. 1990

M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
Pharmaceuticals Research Center, Kanebo Ltd., Osaka, Japan.

Several types of quinazoline derivatives were prepared and examined for anticonvulsive and antihypoxic activities. Many compounds showed potent anticonvulsive activity, and their anticonvulsive profile is similar to that of phenytoin. The analysis of quantitative structure-activity relationships indicated that the anticonvulsive activity was parabolically related to the lipophilicity of the compounds. Most of the 4-alkoxyquinazolines showed potent anticonvulsive and antihypoxic activities. It is confirmed that there is a good correlation between the potencies of these activities.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
September 1994, Arzneimittel-Forschung,
M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
February 2010, Archiv der Pharmazie,
M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
March 2002, Bioorganic & medicinal chemistry letters,
M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
October 2019, European journal of medicinal chemistry,
M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
January 2014, Current computer-aided drug design,
M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
October 2002, Bioorganic & medicinal chemistry letters,
M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
February 2018, Bioorganic & medicinal chemistry letters,
M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
January 2012, Archives of pharmacal research,
M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
July 2023, RSC medicinal chemistry,
M Hori, and R Iemura, and H Hara, and A Ozaki, and T Sukamoto, and H Ohtaka
December 2016, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!